The Journal of Heart and Lung Transplantation
Volume 27, Issue 7 , Pages 753-759 , July 2008

Current State of Combined Heart–Liver Transplantation in the United States

  • Helen S. Te, MD

      Affiliations

    • Center for Liver Diseases, Department of Medicine, University of Chicago Medical Center, Chicago, Illinois
    • Corresponding Author InformationReprint requests: Helen S. Te, MD, Center for Liver Diseases, University of Chicago Medical Center, 5841 South Maryland Avenue, MC 7120, Chicago, IL 60637. Telephone: 773-702-2395. Fax: 773-834-1288.
    • ,
  • Allen S. Anderson, MD

      Affiliations

    • Section of Cardiology, Department of Medicine, University of Chicago Medical Center, Chicago, Illinois
    • ,
  • J. Michael Millis, MD

      Affiliations

    • Section of Transplant Surgery, Department of Surgery, University of Chicago Medical Center, Chicago, Illinois
    • ,
  • Valluvan Jeevanandam, MD

      Affiliations

    • Section of Cardiac and Thoracic Surgery, Department of Surgery, University of Chicago Medical Center, Chicago, Illinois.
    • ,
  • Donald M. Jensen, MD

      Affiliations

    • Center for Liver Diseases, Department of Medicine, University of Chicago Medical Center, Chicago, Illinois

Received 18 February 2008 ,Revised 18 February 2008 ,Accepted 21 April 2008.

References 

  1. Befeler AS, Schiano TD, Lissoos TW, et al. Successful combined liver–heart transplantation in adults: report of three patients and review of the literature. Transplantation. 1999;68:1423–1427
  2. Starzl TE, Bilheimer DW, Bahnson HT, et al. Heart–liver transplantation in a patient with familial hypercholesterolaemia. Lancet. 1984;i:1382–1383
  3. Porrett PM, Desai SS, Timmins KJ, et al. Combined orthotopic heart and liver transplantation: the need for exception status listing. Liver Transplant. 2004;10:1539–1544
  4. Cohen AS. Amyloidosis. N Engl J Med. 1967;277:522–530
  5. Gillmore JD, Lovat LB, Hawkins PN. Amyloidosis and the liver. J Hepatol. 1999;30(suppl 1):17–33
  6. Shah KB, Inoue Y, Mehra MR. Amyloidosis and the heart: a comprehensive review. Arch Intern Med. 2006;166:1805–1813
  7. Benson MD, Yazaki M, Magy N. Laboratory assessment of transthyretin amyloidosis. Clin Chem Lab Med. 2002;40:1262–1265
  8. Holmgren G, Ericzon BG, Groth CG, et al. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet. 1993;341:1113–1116
  9. Rydh A, Suhr O, Hietala SO, et al. Serum amyloid P component scintigraphy in familial amyloid polyneuropathy: regression of visceral amyloid following liver transplantation. Eur J Nucl Med. 1998;25:709–713
  10. Suhr OB, Herlenius G, Friman S, Ericzon BG. Liver transplantation for hereditary transthyretin amyloidosis. Liver Transplant. 2000;6:263–276
  11. Stangou AJ, Hawkins PN, Heaton ND, et al. Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy: implications for amyloid fibrillogenesis. Transplantation. 1998;66:229–233
  12. Yazaki M, Tokuda T, Nakamura A, et al. Cardiac amyloid in patients with familial amyloid polyneuropathy consists of abundant wild-type transthyretin. Biochem Biophys Res Commun. 2000;274:702–706
  13. Grazi GL, Cescon M, Salvi F, et al. Combined heart and liver transplantation for familial amyloidotic neuropathy: considerations from the hepatic point of view. Liver Transplant. 2003;9:986–992
  14. Olynyk JK, Cullen DJ, Aquilia S, et al. A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med. 1999;341:718–724
  15. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;13:399–408
  16. Alexander J, Kowdley KV. Hereditary hemochromatosis: genetics, pathogenesis, and clinical management. Ann Hepatol. 2005;4:240–247
  17. Beutler E. Hemochromatosis: genetics and pathophysiology. Annu Rev Med. 2006;57:331–347
  18. Adams PC, Deugnier Y, Moirand R, Brissot P. The relationship between iron overload, clinical symptoms, and age in 410 patients with genetic hemochromatosis. Hepatology. 1997;25:162–166
  19. Crawford DH, Jazwinska EC, Cullen LM, Powell LW. Expression of HLA-linked hemochromatosis in subjects homozygous or heterozygous for the C282Y mutation. Gastroenterology. 1998;114:1003–1008
  20. Sallie RW, Reed WD, Shilkin KB. Confirmation of the efficacy of hepatic tissue iron index in differentiating genetic haemochromatosis from alcoholic liver disease complicated by alcoholic haemosiderosis. Gut. 1991;32:207–210
  21. Bacon BR, Olynyk JK, Brunt EM, Britton RS, Wolff RK. HFE genotype in patients with hemochromatosis and other liver diseases. Ann Intern Med. 1999;130:953–962
  22. Guyader D, Jacquelinet C, Moirand R, et al. Noninvasive prediction of fibrosis in C282Y homozygous hemochromatosis. Gastroenterology. 1998;115:929–936
  23. Niederau C, Fischer R, Purschel A, et al. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology. 1996;110:1107–1119
  24. Farrell FJ, Nguyen M, Woodley S, et al. Outcome of liver transplantation in patients with hemochromatosis. Hepatology. 1994;20:404–410
  25. Kowdley KV, Hassanein T, Kaur S, et al. Primary liver cancer and survival in patients undergoing liver transplantation for hemochromatosis. Liver Transplant Surg. 1995;1:237–241
  26. Yu L, Ioannou GN. Survival of liver transplant recipients with hemochromatosis in the United States. Gastroenterology. 2007;133:489–495
  27. Alkofer BJ, Chiche L, Khayat A, et al. Liver transplant combined with heart transplant in severe heterozygous hypercholesterolemia: report of the first case and review of the literature. Transplant Proc. 2005;37:2250–2252
  28. Rela M, Muiesan P, Heaton ND, et al. Orthotopic liver transplantation for hepatic-based metabolic disorders. Transplant Int. 1995;8:41–44
  29. Bahnson HT, Gordon RD. Transplantation of other organs with the heart. Cardiovasc Clin. 1990;20:237–248
  30. Barbir M, Khaghani A, Kehely A, et al. Normal levels of lipoproteins including lipoprotein(a) after liver–heart transplantation in a patient with homozygous familial hypercholesterolaemia. Q J Med. 1992;85:807–812
  31. Offstad J, Schrumpf E, Geiran O, Soreide O, Simonsen S. Plasma exchange and heart–liver transplantation in a patient with homozygous familial hypercholesterolemia. Clin Transplant. 2001;15:432–436
  32. Revell SP, Noble-Jamieson G, Johnston P, et al. Liver transplantation for homozygous familial hypercholesterolaemia. Arch Dis Child. 1995;73:456–458
  33. Valdivielso P, Escolar JL, Cuervas-Mons V, et al. Lipids and lipoprotein changes after heart and liver transplantation in a patient with homozygous familial hypercholesterolemia. Ann Intern Med. 1988;108:204–206
  34. Detry O, Honore P, Meurisse M, et al. Advantages of inferior vena caval flow preservation in combined transplantation of the liver and heart. Transplant Int. 1997;10:150–151
  35. Olivieri NF, Liu PP, Sher GD, et al. Combined liver and heart transplantation for end-stage iron-induced organ failure in an adult with homozygous beta-thalassemia. N Engl J Med. 1994;330:1125–1127
  36. Calne RY. Immunological tolerance—the liver effect. Immunol Rev. 2000;174:280–282
  37. Jiang M, Han D. Auxiliary liver–heart transplantation in the rat: a new microsurgical model inducing tolerance. Transplant Proc. 2004;36:1607–1609
  38. Pinderski LJ, Kirklin JK, McGiffin D, et al. Multi-organ transplantation: is there a protective effect against acute and chronic rejection?. J Heart Lung Transplant. 2005;24:1828–1833
  39. Creput C, Durrbach A, Samuel D, et al. Incidence of renal and liver rejection and patient survival rate following combined liver and kidney transplantation. Am J Transplant. 2003;3:348–356
  40. Olausson M, Mjornstedt L, Norden G, et al. Successful combined partial auxiliary liver and kidney transplantation in highly sensitized cross-match positive recipients. Am J Transplant. 2007;7:130–136
  41. Gutierrez A, Crespo M, Mila J, et al. Outcome of simultaneous liver–kidney transplantation in highly sensitized, crossmatch-positive patients. Transplant Proc. 2003;35:1861–1862

 Supported in part by Health Resources and Services Administration Contract No. 234-2005-370011C. The content is the responsibility of the authors and does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the U.S. Government.

PII: S1053-2498(08)00349-5

doi: 10.1016/j.healun.2008.04.004

The Journal of Heart and Lung Transplantation
Volume 27, Issue 7 , Pages 753-759 , July 2008

Article Tools

* Image Usage & Resolution